Point of Care Testing Market Size - By Product, By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Prescription (OTC Testing, Prescription-bas

Point of Care Testing Market Size - By Product, By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Prescription (OTC Testing, Prescription-based Testing), By Application, By End-use – Global Forecast 2023 - 2032


The point of care testing market is expected to witness massive growth through 2030 owing to increasing number of patients with acute illnesses.

Recently, testing in hospitals saw a decline due to the risk of exposure to the novel coronavirus in these settings, which fueled product demand as point of care testing offers flexibility with regards to location. Additionally, rapid testing, a pivotal advantage of point of care assays, has also positively influenced market uptake during the COVID-19 pandemic.

Notably, surging research emphasis by industry players has been beneficial for the product landscape, which has enhanced overall market dynamics. For instance, in June 2022, LumiraDx, a UK-based diagnostics company reported that it had gained CE Mark for its product, the Amira Analyzer. This portable instrument is used for rapid COVID-19 testing.

The point of care testing market has been bifurcated on the basis of technology, application, product, prescription, end-use, and region.

On the basis of product, the market has been bifurcated into cardiometabolic testing products, coagulation testing products, tumor/cancer marker testing products, Drug-of-Abuse (DoA) testing products, cholesterol testing products, glucose monitoring, infectious disease testing products, pregnancy and fertility testing products, urinalysis testing products, hematology testing products, fecal occult testing products, and other products. Among these, the hematology testing products segment was valued at approximately $3,891.7 million in 2021 and is speculated to amass notable gains over 2022-2030.

In terms of technology, the point of care testing market has been segmented into dipsticks, molecular diagnostics, agglutination assays, solid phase, biosensors, flow-through, immunoassays, microfluidics, and lateral flow assays. The molecular diagnostics segment is expected to register a CAGR of around 8.0% over the analysis timeframe.

In context of prescription, the market has been divided into prescription-based testing and OTC testing. The prescription-based testing segment contributed to a market share of roughly 46.1% in 2021 and is estimated to exhibit solid growth in the upcoming time period.

Based on application, the point of care testing market has been divided into infectious disease testing, Drug-of-Abuse (DoA) testing, pregnancy testing, cardio metabolic testing, nephrology testing, blood glucose testing, cancer biomarker testing, and other applications. The infectious disease testing segment is set to witness steady growth, expanding at around 8.1% CAGR through the review period.On the basis of end-use, the market has been divided into diagnostic centers, home-care settings, hospitals, research laboratories, and others. The research laboratories segment reached more than $4,111.8 million in revenue in 2021.

On the regional front, the point of care testing market in Latin America accounted for nearly 5.8% of the overall industry revenue in 2021. On the other hand, the Middle East & Africa point of care testing industry is set to experience robust growth at a CAGR of about 8.6% over the forecast period.


Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.2.1 Data collection
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global point of care testing market 360 degree synopsis, 2018 – 2032 (Revenue)
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Technology trends
2.6 Prescription trends
2.7 Application trends
2.8 End-use trends
Chapter 3 Point of Care Testing Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Pricing analysis, by cardiac markers, 2022
3.5 Regulatory landscape
3.6 Industry impact forces
3.6.1 Growth drivers
3.6.1.1 Upward trend in disease prevalence among developing countries
3.6.1.2 Surging number of pathology labs and services equipped with advanced diagnostic equipment in North America
3.6.1.3 Technological advancements
3.6.1.4 Increasing R&D investment
3.6.2 Industry pitfalls & challenges
3.6.2.1 Stringent regulatory framework
3.6.2.2 High cost of product development
3.7 Growth potential analysis
3.7.1 By product
3.7.2 By technology
3.7.3 By prescription
3.7.4 By application
3.7.5 By end-use
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company market share analysis, 2022 (by region)
4.2.1 Global market share analysis, 2022
4.2.2 North America
4.2.3 Europe
4.2.4 Asia Pacific
4.2.5 Latin America
4.2.6 MEA
4.3 Competitive analysis of major market players, 2022
4.4 Company positioning matrix, 2022
4.5 Strategy outlook matrix, 2022
Chapter 5 Point of Care Testing Market Estimates and Forecast, By Product (Revenue)
5.1 Key trends, by product
5.2 Glucose monitoring
5.2.1 Strips
5.2.2 Meters
5.2.3 Lancets
5.3 Cardiometabolic testing products
5.3.1 Cardiac marker testing products
5.3.1.1 hsTnl
5.3.1.2 BNP
5.3.1.3 D-dimer
5.3.1.4 CK-MB
5.3.1.5 Myoglobin
5.3.1.6 Others
5.3.2 Blood gas/electrolytes testing products
5.3.3 HBA1C testing products
5.4 Infectious disease testing products
5.4.1 Influenza testing products
5.4.2 HIV testing products
5.4.3 Hepatitis C testing products
5.4.4 Sexually transmitted disease (STD) testing products
5.4.5 Healthcare-associated infection (HAI) testing products
5.4.6 Respiratory infection testing products
5.4.7 Tropical disease testing products
5.4.8 Others
5.5 Coagulation testing products
5.5.1 PT/INR testing products
5.5.2 Activated clotting time (ACT/APTT) testing products
5.6 Pregnancy and fertility testing products
5.6.1 Pregnancy testing products
5.6.2 Fertility testing products
5.7 Tumor/cancer marker testing products
5.8 Cholesterol testing products
5.9 Hematology testing products
5.10 Drug-of-abuse (DoA) testing products
5.11 Fecal occult testing products
5.12 Urinalysis testing products
5.13 Others
Chapter 6 Point of Care Testing Market Estimates and Forecast, By Technology (Revenue)
6.1 Key trends, by technology
6.2 Lateral flow assays
6.3 Dipsticks
6.4 Microfluidics
6.5 Molecular diagnostics
6.6 Immunoassays
6.7 Agglutination assays
6.8 Flow-through
6.9 Solid phase
6.10 Biosensors
Chapter 7 Point of Care Testing Market Estimates and Forecast, By Prescription (Revenue)
7.1 Key trends, by prescription
7.2 OTC testing
7.3 Prescription-based testing
Chapter 8 Point of Care Testing Market Estimates and Forecast, By Application (Revenue)
8.1 Key trends, by application
8.2 Cardio metabolic testing
8.3 Infectious disease testing
8.4 Nephrology testing
8.5 Drug-of-abuse (DoA) testing
8.6 Blood glucose testing
8.7 Pregnancy testing
8.8 Cancer biomarker testing
8.9 Others
Chapter 9 Point of Care Testing Market Estimates and Forecast, By End-Use (Revenue)
9.1 Key trends, by end-use
9.2 Hospitals
9.3 Diagnostic centers
9.4 Research laboratories
9.5 Home-care settings
9.6 Others
Chapter 10 Point of Care Testing Market Estimates and Forecast, By Region (Revenue)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Switzerland
10.3.7 The Netherlands
10.3.8 Denmark
10.3.9 Poland
10.3.10 Sweden
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 New Zealand
10.4.7 Thailand
10.4.8 Vietnam
10.4.9 Indonesia
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Colombia
10.5.5 Chile
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Turkey
Chapter 11 Company Profiles
11.1 Abaxis
11.2 Abbott Laboratories
11.3 ACON Laboratories, Inc
11.4 Accubiotech Co, Ltd.
11.5 Becton, Dickinson and Company
11.6 bioLytical Laboratories Inc
11.7 BioMerieux SA
11.8 Bio-Rad Laboratories, Inc
11.9 HemoCue AB (Danaher Corporation)
11.10 Dexcom, Inc
11.11 Dragerwerk Ag & Co
11.12 LifeScan IP Holdings, LLC
11.13 Medtronic Plc
11.14 Meridian Bioscience
11.15 Nova Biomedical
11.16 OraSure Technologies
11.17 F. Hoffmann-La Roche
11.18 Siemens Healthineers AG
11.19 Sysmex Corporation
11.20 Trinity Biotech

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings